Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference37 articles.
1. Trontell A. How the US Food and Drug Administration defines and detects adverse drug events. Curr Ther Res Clin Exp. 2001;62:641–9.
2. US Food and Drug Administration. Reports received and reports entered into FAERS by year (as of November 15, 2015). http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070434.htm Accessed 10 Dec 2016.
3. Lindquist M. VigiBase, the WHO Global ICSR Database System: basic facts. Drug Inf J. 2008;42:409–19.
4. European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP)—module IX—signal management. EMA/827661/2011. 2012. http://www.ema.europa.eu/ema/index . Accessed 23 Mar 2016 (online).
5. Bossard JB, Ponté C, Dupouy J, Lapeyre-Mestre M, Jouanjus E. Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French Pharmacovigilance Database. Clin Drug Investig. 2016;36:735–42.
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献